Glucagon-Like Peptide 1 and Glucose-Dependent Insulinotropic Polypeptide Analogues as Novel Treatments for Alzheimer’s and Parkinson’s Disease

Cardiovascular Endocrinology
doi 10.1097/xce.0000000000000087
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search